Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Insight Pharma Reports | Epigenetics Technologies, Applications, and the Commercial Landscape

Epigenetics Technologies, Applications, and the Commercial Landscape

Epigenetics is one of the fastest-growing areas of the biological sciences. It’s also a budding industry. This new report offers in-depth analysis of:

* The definition, history, and current status of epigenetics

* Current and potential commercial applications

* An epigenetic approach to cancer etiology

* The epigenetics of noncancerous diseases

* DNA methylation and histone modifications as biomarkers

* The companies involved and their products

* Epigenetic therapeutics: demethylating agents, histone modifications, and combinations

* The drivers of the epigenetics industry, plus recent major industry deals and patent applications

* Results of a quantitative online survey of individuals involved in epigenetics R&D

Epigenetics: Technologies, Applications, and the Commercial Landscape provides an overview of the scientific and technological landscape from which both the diagnostic and therapeutic sectors of the nascent “epigenetics industry” are emerging, plus a qualitative analysis of the scientific, technological, and commercial achievements and challenges facing both sectors.

The number of peer-reviewed research articles being published on epigenetics is increasing practically exponentially.

Biologists are recognizing that to understand human health and disease, they need to know more than the DNA sequence of any genes. Equally, if not more important, they need to know how cells use the information encoded in the genome. That information is essentially stagnant if a gene lies dormant. What turns genes on and off, and under what circumstances? That is what epigenetics is all about: how genomic information encoded in the DNA sequence is regulated by various nonDNA factors. The science and technology of epigenetics are aimed at understanding and, ultimately, manipulating the various chemical and physical chromatin modifications that control gene expression.

This report focuses on the 2 major types of epigenetic control factors:

* DNA methylation patterns formed by the presence of methyl molecules (-CH3) attached to CpG dinucleotides along the entire length of the DNA double helix

* Various covalent modifications to the histone proteins around which the DNA helix is wound

Epigenetics: Technologies, Applications, and the Commercial Landscape is a valuable tool for anyone involved in epigenetics R&D, portfolio management, and commercialization of diagnostics and therapeutics.

About the Author:

Leslie A. Pray, PhD, is a science writer and consultant to the Forum on Microbial Threats at the National Academy of Sciences. She has written extensively on a range of genetic, biotechnology, infectious disease, public health policy, and higher education issues for The Scientist, Genomics and Proteomics, The Chronicle of Higher Education, Orion, the American Chemical Society, the American Association for the Advancement of Science, Oak Ridge National Laboratory, and the CBR Institute for Biomedical Research, among others. Dr. Pray received her PhD in population genetics from the University of Vermont and her BA degree from the University of California, Berkeley. An elected member of Sigma Xi, she has been the recipient of numerous scientific research awards, including an American Society of Naturalists Young Investigator Award and a National Science Foundation Environmental Biology Postdoctoral Fellowship.

Length: 130 pages

Date published: February 2008
Table of Contents

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions